A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness (JDDJ - Eli Lilly)

Long Study Name: A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness

Study Type: Muscle Intervention

Study Purpose:
This study is being done to see how safe an investigational drug LY2495655 is and how well it will work to help people with muscle wasting.  Muscle wasting includes shrinking of the muscle and weakness.  This can occur when a muscle is no longer as active as usual. 

Study Design: 
To test if LY2495655 increases lean body mass. Lean body mass is a guess of how much you weigh without bones or fat. Lean body mass measures the muscle only.

Study Qualifications:

  • Age:75 and older and have fallen in the last year
  • Have Generalized Muscle weakness

Study Duration: 42 weeks

Study Benefits:

  • The study drug could increase muscle mass and reduce your risk of falling.

Study Contact:

If you are interested in the Lilly study, call 336-713-8243 or email Patricia Wittmer at pwittmer@wakehealth.edu

Quick Reference

Gerontology and Geriatric Medicine

Geriatric Administration
336-713-8570
Geriatric Clinic
336-713-8250
Geriatric Research
336-713-8539
Elder Law Clinic
336-713-8630

Find A Doctor Ways to Give
Last Updated: 08-26-2013
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.